Biocon Ltd. (BIOCON) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 201791, "name": "Biocon", "stock_name": "Biocon", "full_name": "Biocon Ltd.", "name_url": "stocks-analysis/biocon", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "426.10", "chg": -0.25, "chgp": "-0.06%", "dir": -1, "prev_price": "426.35", "mcapval": "69,906.00 Cr", "mcap": "Mid Cap", "scripcode": 532523, "symbol": "BIOCON", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE376G01013", "curr_date": "Aug 10, 03:30 PM", "curr_time": "01:52 AM", "last_traded_at": "Aug 10, 03:30 PM IST", "bse_nse_vol": "24.21 lacs", "exc_status": "Active", "traded_date": "Aug 10, 2026", "traded_date_str": "2026 08 10", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Biocon Ltd. Reports Flat Quarterly Performance Amid Margin Pressures", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-reports-flat-quarterly-performance-amid-margin-pressures-4138940", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BioconLtd_fintrenddot_4138940.png", "date": "2026-08-06 08:00:07", "description": "Biocon Ltd., a key player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, marking a notable shift from its previously positive growth trajectory. Despite a strong nine-month PAT of ₹782.21 crores and a healthy debt-equity ratio, the company faces challenges with declining quarterly profits and margin contractions, prompting a downgrade in its Mojo Grade from Buy to Hold." }, { "title": "Biocon Ltd. is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-is-rated-buy-by-marketsmojo-4137770", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BioconLtd_mojoScore_4137770.png", "date": "2026-08-05 10:10:55", "description": "Biocon Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 13 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 August 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "When is the next results date for Biocon Ltd.?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-biocon-ltd-4127603", "imagepath": "", "date": "2026-07-29 23:16:59", "description": "The next results date for Biocon Ltd. is scheduled for August 5, 2026...." }, { "title": "Biocon Ltd. is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-is-rated-buy-4120159", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BioconLtd_mojoScore_4120159.png", "date": "2026-07-25 10:10:28", "description": "Biocon Ltd. is rated Buy by MarketsMOJO, with this rating last updated on 13 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 July 2026, providing investors with the most up-to-date insight into the company’s performance and outlook." }, { "title": "Biocon Ltd Sees Significant Open Interest Surge Amid Mixed Price Action", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-significant-open-interest-surge-amid-mixed-price-action-4119597", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BioconLtd_oi_spurts_by_underlying_4119597.png", "date": "2026-07-24 15:00:15", "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.84% surge in open interest in its derivatives segment, signalling increased market activity and shifting investor positioning. Despite this, the stock has experienced a mild price correction over the past three days, reflecting a complex interplay between bullish bets and short-term profit-taking." }, { "title": "Biocon Ltd Sees Significant Open Interest Surge Amid Mixed Price Action", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-significant-open-interest-surge-amid-mixed-price-action-4119492", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BioconLtd_oi_spurts_by_underlying_4119492.png", "date": "2026-07-24 14:00:14", "description": "Biocon Ltd., a mid-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.37% increase in open interest in its derivatives segment, signalling heightened market activity despite a modest price decline. This surge in open interest, coupled with volume patterns and recent price movements, offers valuable insights into evolving market positioning and potential directional bets among investors." }, { "title": "Biocon Ltd Gains 4.43%: 5 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-gains-443-5-key-factors-driving-the-weeks-momentum-4108149", "imagepath": "", "date": "2026-07-19 13:01:11", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>13 Jul:</strong> Sharp open interest surge amid mixed market signals</p>\n <p><strong>14 Jul:</strong> New 52-week high at Rs.442.45 and Mojo Grade upgraded to Buy</p>\n <p><strong>16 Jul:</strong> Another 52-week high near Rs.444.5, marking sustained momentum</p>\n <p><strong>17 Jul:</strong> Week closes at Rs.437.00, up 4.43% vs Sensex flat</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.418.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=..." }, { "title": "Broad-Based Technical Strength Lifts Biocon Ltd. to 52-Week High of Rs 444.5", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-hits-new-52-week-high-marking-significant-market-milestone-4105104", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BioconLtd_priceRelatedfactors_4105104.png", "date": "2026-07-16 10:35:17", "description": "With a close approach to its 52-week high at Rs 444.5 on 16 Jun 2026, Biocon Ltd. has demonstrated sustained momentum, outperforming its sector and the broader market. Trading above all key moving averages, the stock’s technical indicators collectively signal robust upward momentum, underscoring the strength behind this rally." }, { "title": "Biocon Ltd Sees Sharp Surge in Open Interest Signalling Strong Market Positioning", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-sharp-surge-in-open-interest-signalling-strong-market-positioning-4100886", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/BioconLtd_oi_spurts_by_underlying_4100886.png", "date": "2026-07-14 11:00:08", "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment on 14 Jul 2026, signalling heightened market activity and evolving investor positioning. The stock also hit a new 52-week high, reflecting robust bullish sentiment amid broader sector outperformance." } ], "total": 5866, "sid": "201791", "stock_news_url": "https://www.marketsmojo.com/news/biocon-201791" }, "announcements": [ { "details": "Biocon Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Biocon Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "09-Dec-2019" }, { "details": "Biocon Limited has informed the Exchange regarding a press release dated December 02, 2019, titled \"Biocon and Mylan Launch Trastuzumab Biosimilar, Ogivri (trastuzumab-dkst), in the U.S.\".", "source": "NSE", "caption": "Biocon Limited - Press Release", "datetime": "03-Dec-2019" }, { "details": "Biocon Limited has informed the Exchange regarding a press release dated November 27, 2019, titled \"", "source": "NSE", "caption": "Biocon Limited - Press Release", "datetime": "27-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Biocon Ltd. has declared <strong>10%</strong> dividend, ex-date: 03 Jul 26", "dt": "2026-07-03", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Biocon Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 12 Jun 19", "dt": "2019-06-12", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

13 Jul: Sharp open interest surge amid mixed market signals

14 Jul: New 52-week high at Rs.442.45 and Mojo Grade upgraded to Buy

16 Jul: Another 52-week high near Rs.444.5, marking sustained momentum

17 Jul: Week closes at Rs.437.00, up 4.43% vs Sensex flat

Week Open

Rs.418.45

Week Close

Read full news article

Broad-Based Technical Strength Lifts Biocon Ltd. to 52-Week High of Rs 444.5

2026-07-16 10:35:17

With a close approach to its 52-week high at Rs 444.5 on 16 Jun 2026, Biocon Ltd. has demonstrated sustained momentum, outperforming its sector and the broader market. Trading above all key moving averages, the stock’s technical indicators collectively signal robust upward momentum, underscoring the strength behind this rally.

Read full news article

Biocon Ltd Sees Sharp Surge in Open Interest Signalling Strong Market Positioning

2026-07-14 11:00:08

Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed a significant surge in open interest (OI) in its derivatives segment on 14 Jul 2026, signalling heightened market activity and evolving investor positioning. The stock also hit a new 52-week high, reflecting robust bullish sentiment amid broader sector outperformance.

Read full news article